Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response of a chemo-resistant triple-negative breast cancer patient to a combination of p62-encoding plasmid, Elenagen, and CMF chemotherapy

Published:2020-01-21 Issue:3 Volume:11 Page:294-299
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Ponomarenko Dmitry M.¹,Gabai Vladimir L.²³,Sufianov Albert A.⁴⁵,Kolesnikov Sergey I.⁶⁷⁸,Shneider Alexander M.²⁵⁹

Affiliation:

1. Irkutsk State Medical Academy of Postgraduate Education, Irkutsk Regional Cancer Dispensary, Irkutsk, Russian Federation

2. CureLab Oncology, Inc, Dedham, MA, USA

3. Department of Biochemistry, Boston University School of Medicine, Boston, MA, USA

4. Federal Center of Neurosurgery, Tyumen, Russian Federation

5. Sechenov First Moscow State Medical University, Moscow, Russian Federation

6. Russian Academy of Sciences, Moscow, Russian Federation

7. Lomonosov Moscow State University, Moscow, Russian Federation

8. Research Center of Family Health and Reproduct ion Problems, Irkutsk, Russian Federation

9. Department of Molecular Biology, Ariel University, Ariel, Israel

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fusobacterium nucleatum-mimicking nanovehicles to overcome chemoresistance for breast cancer treatment by eliminating tumor-colonizing bacteria;Chem;2024-06

2. Clinical efficacy of plasmid encoding p62/SQSTM1 (Elenagen) in combination with gemcitabine in patients with platinum-resistant ovarian cancer: a randomized controlled trial;Frontiers in Oncology;2024-02-12

3. Cancer Vaccines for Triple-Negative Breast Cancer: A Systematic Review;Vaccines;2023-01-09

4. p62/SQSTM1 indirectly mediates remote multipotent mesenchymal cells and rescues bone loss and bone marrow integrity in ovariectomized rats;Journal of Cellular Physiology;2022-12-24

5. P62/SQSTM1 beyond Autophagy: Physiological Role and Therapeutic Applications in Laboratory and Domestic Animals;Life;2022-04-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3